Both companies may succeed in this industry.

Shares of luxury cruise operator Viking (NYSE:VIK) jumped 4.8% in the afternoon session after positive results from rival ...

Viking Therapeutics CEO Brian Lian said pharmaceutical companies are showing broader and deeper strategic interest in weight-loss drug deals than is immediately visible, as the global obesity ...

NVO and VKTX face rising competition and setbacks as investors weigh scale, pipelines and execution risks in the crowded ...

Despite a challenging year, the company has a lot to look forward to in the coming years.

We recently published 10 Big Names Delivering Outsized Gains. Viking Therapeutics Inc. (NASDAQ:VKTX) was one of the top performers on Wednesday. Viking Therapeutics grew its share prices by 11.89 ...

Financial giants have made a conspicuous bullish move on Viking Therapeutics. Our analysis of options history for Viking Therapeutics VKTX revealed 12 unusual trades. Delving into the details, we ...

Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $32.22, moving -5.49% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.03% ...

The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...

Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics (NASDAQ:VKTX). And retail traders should know. We noticed this today when the positions showed up on publicly ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the price target to $58 from $50. From 2017 to 2019, VIK’s pre-pandemic annual ...